Editorial: IL-1 Inhibition

Editorial: IL-1 Inhibition

Bibliographic Details
Main Authors:	Francesca Oliviero, Paolo Sfriso, Leonardo Punzi, Jean-Michel Dayer
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2019-02-01
Series:	Frontiers in Pharmacology
Subjects:	IL-1 (interleukin-1) IL-1 blockade anakinra canakinumab rheumatic diseases inflammatory chronic diseases
Online Access:	https://www.frontiersin.org/article/10.3389/fphar.2019.00087/full

Similar Items

A snapshot on the on-label and off-label use of the interleukin-1 inhibitors in Italy among rheumatologists and pediatric rheumatologists: a nationwide multi-center retrospective observational study
by: Antonio Vitale, et al.
Published: (2016-10-01)

Response to Interleukin-1 Inhibitors in 140 Italian Patients with Adult-Onset Still’s Disease: A Multicentre Retrospective Observational Study
by: Serena Colafrancesco, et al.
Published: (2017-06-01)

IL-1 Inhibitors in the Treatment of Monogenic Periodic Fever Syndromes: From the Past to the Future Perspectives
by: Hana Malcova, et al.
Published: (2021-02-01)

Systemic autoinflammation with intractable epilepsy managed with interleukin-1 blockade
by: Allen D. DeSena, et al.
Published: (2018-02-01)

IL-1 inhibition in systemic juvenile idiopathic arthritis
by: Gabriella Giancane, et al.
Published: (2016-12-01)

The role of IL-1 inhibition in systemic juvenile idiopathic arthritis: current status and future perspectives
by: Toplak N, et al.
Published: (2018-06-01)

Management of adult-onset Still’s disease with interleukin-1 inhibitors: evidence- and consensus-based statements by a panel of Italian experts
by: Serena Colafrancesco, et al.
Published: (2019-12-01)

Scoping Review on Use of Drugs Targeting Interleukin 1 Pathway in DIRA and DITRA
by: Francisco Gómez-García, et al.
Published: (2018-11-01)

Failure of anti Interleukin-1 β monoclonal antibody in the treatment of recurrent pericarditis in two children
by: Sara Signa, et al.
Published: (2020-06-01)

A child with resistant Kawasaki disease successfully treated with anakinra: a case report
by: J. Sánchez-Manubens, et al.
Published: (2017-04-01)

Experiences with IL-1 blockade in systemic juvenile idiopathic arthritis – data from the German AID-registry
by: Elke Lainka, et al.
Published: (2021-03-01)

The Use of Interleukine-1 Inhibitors in Familial Mediterranean Fever Patients: A Narrative Review
by: Véronique Hentgen, et al.
Published: (2020-05-01)

Interleukin-1 Blockade in Polygenic Autoinflammatory Disorders: Where Are We now?
by: Hana Malcova, et al.
Published: (2021-01-01)

Clinical experience with the interleukin-1β blocker canakinumab in patients with chronic tophaceous gout: abolishment of arthritis and prevention of exacerbations when allopurinol is used
by: M. S. Eliseev, et al.
Published: (2015-06-01)

Editorial: IL-1 Family Members in Health and Disease
by: Elizabeth Brint, et al.
Published: (2019-11-01)

From supernatants to cytokines: a personal view on the early history of IL-1, IL-1Ra, TNF and its inhibitor in rheumatology
by: Jean-Michel Dayer
Published: (2018-05-01)

Hyperphosphatemic Familial Tumoral Calcinosis With Galnt3 Mutation: Transient Response to Anti‐Interleukin‐1 Treatments
by: Astrid Dauchez, et al.
Published: (2019-07-01)

The IL-1 Antagonist Anakinra Attenuates Glioblastoma Aggressiveness by Dampening Tumor-Associated Inflammation
by: Max Hübner, et al.
Published: (2020-02-01)

The safety of live-attenuated vaccines in patients using IL-1 or IL-6 blockade: an international survey
by: Jerold Jeyaratnam, et al.
Published: (2018-03-01)

Muckle–Wells syndrome: clinical perspectives
by: Tran TA
Published: (2017-07-01)

Development and Role in Therapy of Canakinumab in Adult-Onset Still’s Disease
by: Paola Galozzi, et al.
Published: (2018-09-01)

Drug Retention Rate and Predictive Factors of Drug Survival for Interleukin-1 Inhibitors in Systemic Juvenile Idiopathic Arthritis
by: Jurgen Sota, et al.
Published: (2019-01-01)

Subclinical TRAPS treated with canakinumab
by: M. Amatruda, et al.
Published: (2021-08-01)

Schnitzler syndrome, a rare autoinflammatory disease. Complete response to IL-1 blockade
by: Paola Faggioli, et al.
Published: (2017-12-01)

A Brief History of IL-1 and IL-1 Ra in Rheumatology
by: Jean-Michel Dayer, et al.
Published: (2017-05-01)

Schnitzler syndrome: A review of literature, the authors’ observation, and experience with the interleukin-1 inhibitor canakinumab
by: S O Salugina, et al.
Published: (2017-11-01)

Potential of IL-1, IL-18 and Inflammasome Inhibition for the Treatment of Inflammatory Skin Diseases
by: Gabriele Fenini, et al.
Published: (2017-05-01)

Use of anakinra in severe COVID-19: A case report
by: Giovanni Filocamo, et al.
Published: (2020-07-01)

The Role of Interleukin 1β in the Pathogenesis of Lung Cancer
by: Edward B. Garon, MD, et al.
Published: (2020-03-01)

The role of interleukin 1 in the development of human diseases
by: E. L. Nasonov
Published: (2019-04-01)

Familial Mediterranean Fever: Current Approaches to Diagnosis and Treatment
by: Mikhail M. Kostik, et al.
Published: (2018-12-01)

Use of Anakinra in Patients with Cryopyrin-Associated Periodic Syndromes and Other Autoinflammatory Diseases
by: Mikhail M. Kostik
Published: (2016-12-01)

IL-1 Family Members in Cancer; Two Sides to Every Story
by: Kevin J. Baker, et al.
Published: (2019-06-01)

IL-1β Antibody Protects Brain from Neuropathology of Hypoperfusion
by: Dominic Quintana, et al.
Published: (2021-04-01)

Unveiling the Efficacy, Safety, and Tolerability of Anti-Interleukin-1 Treatment in Monogenic and Multifactorial Autoinflammatory Diseases
by: Alessandra Bettiol, et al.
Published: (2019-04-01)

The Efficacy, Safety and Tolerability of Canakinumab in the Treatment of Familial Mediterranean Fever: A Systematic Review of the Literature
by: Kacar M, et al.
Published: (2020-03-01)

Therapy with canakinumab for adult-onset still's disease
by: E. L. Nasonov
Published: (2019-04-01)

Avaliação da expressão de interleucina 1 beta (IL-1β) e antagonista do receptor de interleucina 1 (IL-1Ra) em pacientes com hanseníase Evaluation of the expression of interleukin 1 beta(IL-1β) and interleukin 1 receptor antagonist (IL-1Ra) in leprosy patients
by: Rosane Dias Costa, et al.
Published: (2008-01-01)

Anti-inflammatory Therapy for Coronary Atherosclerotic Heart Disease: Unanswered Questions Behind Existing Successes
by: Jun Ma, et al.
Published: (2021-02-01)

FAMILIAL MEDITERRANEAN FEVER: ASSESSING THE OVERALL CLINICAL IMPACT AND FORMULATING TREATMENT PLANS
by: Donato Rigante, et al.
Published: (2019-04-01)